Best UK share: I think it’s a rare opportunity to buy this FTSE 100 stock at a low price

Manika Premsingh thinks this is one of the best UK shares to buy after the stock market crash, because of its high potential and still soft share price.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I reckon that the best UK shares to buy now are those that are still recovering from the stock market crash. They aren’t easy to come by now, though. The FTSE 100 index has made consistent gains in the last two months. It rose 4% in May and has seen an almost 5% increase in June. As a result many shares’ prices are back to their pre-crash levels. 

But for the eagle-eyed investor, there are still some good buys to be made. Think about this. Sure, the FTSE 100 index has risen, but it’s still not at the pre-crash levels. As a matter of fact, it’s 17% lower in June than in January. This means that at least some FTSE 100 shares are still at muted prices. Some of these were underperformers even before the stock market crash occurred. But there are others too. These ones have been hit disproportionately by the corona crisis. 

Best UK share to buy in the recession

One of them is medical devices manufacturer Smith & Nephew (LSE: SN). Typically , it would be relatively insulated in a recession. Healthcare spending is less likely to be hit during such times than say, spending on luxury goods and holidays. As a result, stocks like healthcare are among the best UK shares to hold during economic slowdowns. 

But this recession is an exception. It has gone hand in hand with cross-country lockdowns. As a result, elective surgeries have taken a backseat. Some of SN’s products are associated with these. For instance, it manufactures knee and hip implants for replacement surgeries, which aren’t always urgent even if they are important. 

Expect a bounce back

Smith & Nephew’s performance has been hit because of this. It showed a 7.6% revenue fall in the first quarter of the year. With lockdowns easing only well into the second quarter, I think investors should be prepared for one more poor update. After that, though, I think it will bounce back. It has been a profit-making company in the past, and much like other companies, its 2020 performance should be seen as a blip.

SN’s share price sensitivity can also be high. I wrote about it in October last year, after it fell 8% in a day on the sudden news that it’s then CEO, Kamal Nawana, had resigned. However, his replacement was appointed quickly and the stock price was well on it’s way up again. Covid-19 and the ensuing stock market crash have taken the wind out of its sails, for sure. But I do think that the share has the potential to start rising fast again. 

Until then, I think it’s one of the best UK shares to consider buying. At its last close, the SN share price was at £15.2, which is 23% below the highs seen earlier in 2020. I think it’s only a matter of time before FTSE 100 investors see its potential. I’d buy SN before that happens, and its price starts running up.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

Starting with nothing? Here’s why now is the perfect time to start building a passive income

Many are worried that 2026 might be a bad time to start investing in stocks and shares. Our Foolish author…

Read more »

ISA coins
Investing Articles

Decided not to bother with a Stocks and Shares ISA? You might be missing these 3 things!

With a fresh annual allowance for contributing to a Stocks and Shares ISA upon us, what might people who don't…

Read more »

GSK scientist holding lab syringe
Investing Articles

Why is everyone buying GSK shares?

GSK shares have been outperforming the FTSE 100 in 2026. Paul Summers takes a closer look and asks whether this…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£10,000 invested in easyJet shares at the start of 2026 is now worth…

Anyone buying easyJet shares will have endured a rough ride since January. Paul Summers wonders whether things could get even…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

5 years ago, £5,000 bought 2,645 Barclays shares. But how many would it buy now?

Despite delivering an impressive return since April 2021, Barclays' shares have lagged the FTSE 100's other banks. James Beard considers…

Read more »

Side of boat fuelled by gas to liquids, advertising Shell GTL Fuel
Investing Articles

5 years ago, £5,000 bought 354 Shell shares. But how many would it buy now?

When it comes to Shell’s numbers, most of them are impressive. And it’s no different when looking at the recent…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

I asked ChatGPT if I should buy Aviva, Diageo or BAE Systems stock and it said…

Aviva, Diageo and BAE Systems shares are popular FTSE 100 picks. But which of the three does ChatGPT like the…

Read more »

Tesla car at super charger station
Investing Articles

SpaceX’s IPO threatens to leave the Tesla share price on the forecourt

As Elon Musk starts fuelling the engines for a SpaceX IPO, could the Tesla share price get left in the…

Read more »